Stephen Ayers (@meremrtl) header
Stephen Ayers (@meremrtl) profile picture

RN, BSN, MBA | Purdue 🚂 | Seeking Alpha analyst | Biotech deep dives ↓

Chicago, IL
Joined March 2010
Photo by Stephen Ayers (@meremrtl)Photo by Stephen Ayers (@meremrtl)Photo by Stephen Ayers (@meremrtl)Photo by Stephen Ayers (@meremrtl)Photo by Stephen Ayers (@meremrtl)Photo by Stephen Ayers (@meremrtl)Photo by Stephen Ayers (@meremrtl)Photo by Stephen Ayers (@meremrtl)Photo by Stephen Ayers (@meremrtl)
Pharvaris: CHAPTER-3 Data Lands This Quarter And The Setup Is Favorable $PHVS $XBI $SPY moleculetomarket.substack.co…
2
1
16
5,024
Stephen Ayers retweeted
JUST IN: President Trump declares he’s not concerned about the recent string of major outages — “It’s life.”
603
1,315
1,407
19,627
4,209,028
never fails
Jonah “The Juice” Lipton everyone.
1
827
Stephen Ayers retweeted
241
1,689
162
35,387
1,630,821
$SLS REGAL will turn out to be just a dramatic financing event. The real deal will come with detailed data, FDA scrutiny, etc.
10
1
25
3,759
Stephen Ayers retweeted
thanks for all your hard work team. you earned it
1,412
14,610
1,137
231,742
5,450,609
$SLS $IBRX should join together.
$SLS What an AWESOME interview! Those who didn’t watch it yet .. DO IT ! Great question immediately on the WT1 targeting technology. UP TO 20-30 different cancer types. This won’t be ignored! Just the beginning What a great day really. We did it bulls! Congratulations to everyone here who kept believing and fighting the FUD. We did not give in!
1
4
1,521
Stephen Ayers retweeted
Summit's CRL is a good case in point for the value of FDA disclosure. Summit's statement cited one principal reason for the FDA's rejection. The FDA's letter, posted today, cites four (see two images to right): download.open.fda.gov/crl/CR… $SMMT
2
17
4
95
25,870
Stephen Ayers retweeted
$SLS needs to say more about this.
8
6
50
13,078
Stephen Ayers retweeted
$SLS The company on the call said that they ran the "pre specified" analysis, but they pre-specified ITT, mITT, and Per Protocol analysis and do not identify which one these data are. No commentary on secondaries hitting either. FDA will look at ITT for approval. Why no Q&A? This essentially gives $SLS the ability to produce whatever p-value they want on a "pre specified" basis but in reality, only ITT matters.
12
6
4
86
30,984
Stephen Ayers retweeted
“You hit the pope in the eye with a rosary?” “Jerry I thought he would catch it. We made eye contact!”
Pope Leo struck in the eye by thrown rosary during Peru farewell parade trib.al/tW3W6x4
65
766
6
24,183
431,376
$SLS magically hit 0.035 in an open-label trial. If market comes to their senses, stock will be down to where it was pre-data (~$16/share). Risk/reward was always bad. Let's see full data. It will be scrutinized.
40
2
45
13,248
Stephen Ayers retweeted
It's almost that time of year again when Lexus tries to convince us that it's perfectly normal to buy your partner a luxury vehicle without them knowing
225
1,535
105
55,558
4,456,444
Stephen Ayers retweeted
Probably the most eternally vindicated post on x
15
100
10
2,178
66,358
Stephen Ayers retweeted
ready for Friendsgiving
56
447
39
12,843
2,061,729
Stephen Ayers retweeted
BREAKING: Nvidia employees reportedly called Jensen "Daddy Huang"
423
713
303
13,251
476,398
The scaling law we didn’t know we needed
19
51
9
820
54,336
A) This is absolutely amazing. And, B) Hollywood is so fucked.
Jensen gets a job at Dunder Mifflin. Incredible 😂
120
215
16
6,334
1,364,122
Stephen Ayers retweeted
BREAKING: Former Nvidia CEO Jensen Huang had an intimate relationship with a second employee, Reuters reports.
51
2,524
42
33,465
387,317